99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients
- PMID: 20463837
- PMCID: PMC2868210
99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients
Abstract
The sentinel lymph node was defined as the first lymph node to receive drainage from a primary cancer. The aims of this study were to investigate the efficacy of radiocolloid lymphoscintigraphy and of the hand-held gamma probe procedure for sentinel lymph node biopsy in papillary thyroid carcinoma and to evaluate these results in clinical staging. A total of 99 consecutive papillary thyroid carcinoma patients entered the study. Patients underwent radiocolloid lymphoscintigraphy before surgery. Intra-operative sentinel lymph node localization was performed using a hand-held gamma probe. Patients were observed at follow-up at 2 and 6 months and, thereafter, yearly. Sequential lymphoscintigraphy was able to identify at least one sentinel lymph node in 98/99 cases (99%), using intra-operative hand-held gamma probe, the surgeon was able to detect at least one sentinel lymph node in all cases. Sentinel lymph node metastases were diagnosed in 49%. Overall, 79 patients underwent ablative (131)I therapy. The median value of thyroglobulin in N0 vs. N1 patients was 1 ng/ml vs. 1.9 ng/ml (p = 0.03) and 0.2 ng/ml vs. 1 ng/ml (p = 0.001) before and after (131)I therapy, respectively. The pre-operative lymphoscintigraphy and the intra-operative gamma probe offer significant advantages over the vital dye technique, described in our previous experience. The rate of nodal involvement (49%) is very high considering that no patients had clinically palpable nodes or suspected at echography. (131)I whole body scan and thyroglobulin measurements confirmed sentinel lymph node in papillary thyroid carcinoma as a reliable procedure. In patients classified N0, by sentinel lymph node biopsy, ablative (131)I therapy could be avoided.
Il linfonodo sentinella è stato definito come il primo linfonodo che riceve il drenaggio linfatico dal tumore primitivo. Gli obiettivi di questo studio sono stati indagare l’efficacia della procedura mediante linfoscintigrafia preoperatoria con radio colloide e sonda gamma manuale intraoperatoria per la ricerca del linfonodo sentinella nel carcinoma papillare della tiroide e valutare i risultati nella stadiazione clinica. Novantanove pazienti consecutivi affetti da carcinoma papillare della tiroide sono stati arruolati in questo studio. I pazienti sono stati sottoposti a linfoscintigrafia con radio colloide prima dell’intervento chirurgico. La localizzazione intraoperatoria del linfonodo sentinella è stata realizzata utilizzando una sonda gamma manuale. I pazienti sono stati seguiti nel follow-up a 2, 6 mesi e in seguito annualmente. Il linfonodo sentinella è stato individuato in 98/99 casi (99%) mediante linfoscintigrafia e in tutti i casi mediante la sonda manuale intraoperatoria. Metastasi linfonodali del linfonodo sentinella sono state individuate nel 49% dei casi. Settantanove pazienti sono stati sottoposti a terapia ablativa con 131I. Il valore mediano della tireoglobulina nei pazienti N0 vs. N1 è risultato pari a 1 ng/ml vs. 1,9 ng/ml (p = 0,003) e 0,2 ng/ml vs. 1 ng/ml (p = 0,001) rispettivamente prima e dopo la terapia con 131I. La ricerca del linfonodo sentinella mediante linfoscintigrafia preoperatoria e gamma camera intraoperatoria offrono significativi vantaggi rispetto alla tecnica con il colorante vitale, descritta nella nostra precedente esperienza. La percentuale di metastasi linfonodali pari a 49% è molto alta considerando che nessun paziente presentava linfonodi sospetti né clinicamente né alla ecografia preoperatoria. La scintigrafia total body con 131I e i dosaggi di tireoglobulina hanno confermato l’attendibilità della procedura del linfonodo sentinella nel carcinoma papillare della tiroide. Nei pazienti definiti N0 mediante la tecnica del linfonodo sentinella la terapia con 131I può essere evitata.
Keywords: Cancer; Node metastases; Radiocolloid lymphoscintigraphy; Sentinel lymph node; Thyroid.
Similar articles
-
99Tc Nanocolloid sentinel node procedure in thyroid carcinoma.Langenbecks Arch Surg. 2008 Sep;393(5):705-8. doi: 10.1007/s00423-008-0376-5. Epub 2008 Jul 15. Langenbecks Arch Surg. 2008. PMID: 18626655
-
The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):834-41. doi: 10.1001/jamaoto.2016.1227. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27366869
-
Sentinel node mapping and biopsy in thyroid cancer: a surgical perspective.Biomed Pharmacother. 2006 Sep;60(8):405-8. doi: 10.1016/j.biopha.2006.08.001. Epub 2006 Sep 1. Biomed Pharmacother. 2006. PMID: 16962736
-
The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience.Laryngoscope. 2004 Jan;114(1):2-19. doi: 10.1097/00005537-200401000-00002. Laryngoscope. 2004. PMID: 14709988 Review.
-
The sentinel lymph node biopsy technique in papillary thyroid carcinoma: The issue of false-negative findings.Eur J Surg Oncol. 2020 Jun;46(6):967-975. doi: 10.1016/j.ejso.2020.02.007. Epub 2020 Feb 15. Eur J Surg Oncol. 2020. PMID: 32098735 Review.
Cited by
-
Sentinel lymph node detection in thyroid carcinoma using [68Ga]Ga-tilmanocept PET/CT: a proof-of-concept study.Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):512-520. doi: 10.1007/s00259-023-06449-0. Epub 2023 Sep 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 37773437 Free PMC article.
-
Sentinel lymph node biopsy for papillary thyroid cancer: the effect of dose, tracer and application of massage.Asia Ocean J Nucl Med Biol. 2021 Winter;9(1):9-14. doi: 10.22038/AOJNMB.2020.50491.1345. Asia Ocean J Nucl Med Biol. 2021. PMID: 33392344 Free PMC article.
-
Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions.Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1249-57. doi: 10.1007/s00405-011-1620-0. Epub 2011 May 12. Eur Arch Otorhinolaryngol. 2011. PMID: 21562814 Review.
-
Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study.J Endocrinol Invest. 2014 Sep;37(9):829-34. doi: 10.1007/s40618-014-0112-7. Epub 2014 Jun 21. J Endocrinol Invest. 2014. PMID: 24950750
-
Accuracy of sentinel lymph node mapping in detecting occult neck metastasis in papillary thyroid carcinoma.Arch Endocrinol Metab. 2018 Jun;62(3):296-302. doi: 10.20945/2359-3997000000038. Epub 2018 May 17. Arch Endocrinol Metab. 2018. PMID: 29791655 Free PMC article.
References
-
- Pasieka JL. Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 2001;88:321-2. - PubMed
-
- Pelizzo MR, Rubello D, Merante Boschin I, Piotto A, Pagetta C, Toniato A, et al. Contribution of SLN investigation with 99m Tc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging 2007;34:934-8. - PubMed
-
- Rubello D, Pelizzo MR, Al-Nahhas A, Salvatori M, O’Doherty MJ, Giuliano AE, et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 2006;32:917-21. - PubMed
-
- Rubello D, Nanni C, Merante Boschin I, Toniato A, Piotto A, Rampin L, et al. Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? J Exp Clin Cancer Res 2006;25:483-6. - PubMed
-
- Boschin IM, Toniato A, Piotto A, Ide EC, Casara D, Guolo A, et al. 99Tc Nanocolloid sentinel node procedure in thyroid carcinoma. Langenbecks Arch Surg 2008;393:705-8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical